Legal status · Australia
Is NNC0480-0389 legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. NNC0480-0389 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
NNC0480-0389 in Australia at a glance
| Classification | Investigational, not registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Human studies cited | 3 of 3 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the NNC0480-0389 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
NNC0480-0389 is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What NNC0480-0389 is
A GIP receptor agonist being added to semaglutide in phase 2, with 500 participants. Its mirror image, a GIP antagonist added to semaglutide, is in phase 2 at the same time.
This is the agonist half of the GIP paradox, tested as an add-on rather than as a single molecule. Novo Nordisk makes semaglutide, so pairing it with a separate long-acting GIP receptor agonist is a route to a tirzepatide-like dual mechanism using two drugs instead of one.
Mechanism: A long-acting agonist at the GIP receptor, a class B1 G protein-coupled receptor that raises cyclic AMP. In the pancreatic beta cell that potentiates glucose-stimulated insulin secretion in a glucose-dependent way.
Regulatory history: Investigational. Not approved anywhere. Phase 2 dose finding completed with no published results.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for NNC0480-0389 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
NNC0480-0389 in other countries
Frequently asked questions
Is NNC0480-0389 legal in Australia?
No. NNC0480-0389 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Can I buy NNC0480-0389 in Australia?
No approved product exists to buy. In Australia NNC0480-0389 is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is NNC0480-0389 TGA approved?
No. In Australia NNC0480-0389 is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational. Not approved anywhere. Phase 2 dose finding completed with no published results.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for NNC0480-0389 live on its compound profile.
NNC0480-0389 profileThis page is general information about the regulatory status of NNC0480-0389 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.